Kadmon Holdings, Inc. (NYSE: KDMN) submitted an Abbreviated New Drug Application (ANDA) for KD034, to the U.S. Food and Drug ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE